Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP7 | Q9UHL4 | 3/20 | 0.37 |
| ▸ | OTC | P00480 | 1/20 | 0.34 |
| ▸ | ANPEP | P15144 | 2/20 | 0.33 |
| ▸ | RNPEP | Q9H4A4 | 2/20 | 0.33 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.33 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.33 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.33 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.33 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.33 |
| ▸ | RRM1 | P23921 | 1/20 | 0.32 |
| ▸ | ARG1 | P05089 | 1/20 | 0.32 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.32 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.31 |
| ▸ | DPP4 | P27487 | 1/20 | 0.31 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.31 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.31 |
| ▸ | NPY1R | P25929 | 1/20 | 0.30 |
| ▸ | NPY4R | P50391 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL25356044 | 0.98 | DPP7 (0.36) | DPP7OTCANPEPRNPEPDNPEP | |
| SCHEMBL29106719 | 0.89 | DPP7 (0.41) | DPP7OTCANPEPRNPEPDNPEP | |
| SCHEMBL3133848 | 0.89 | DPP7 (0.41) | DPP7OTCANPEPRNPEPDNPEP | |
| SCHEMBL27926299 | 0.88 | NPY4R (0.39) | DPP7OTCANPEPRNPEPDNPEP | |
| SCHEMBL4586463 | 0.88 | NPY4R (0.39) | DPP7OTCANPEPRNPEPDNPEP | |
| SCHEMBL28111481 | 0.87 | DPP7 (0.40) | DPP7OTCANPEPRNPEPDNPEP | |
| SCHEMBL28427934 | 0.84 | DPP7 (0.35) | DPP7OTCANPEPRNPEPDNPEP | |
| SCHEMBL22160895 | 0.83 | GNAI3 (0.42) | DPP7OTCGNAI3GNAO1GNAI1 | |
| SCHEMBL27866150 | 0.83 | GNAI3 (0.42) | DPP7OTCGNAI3GNAO1GNAI1 | |
| SCHEMBL21122142 | 0.81 | DPP7 (0.36) | DPP7OTCGNAI3GNAO1GNAI1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113195487-A | 2, 3-diaminosuccinyl conjugate linkers | 杭州多禧生物科技有限公司 | 2021-07-30 | — | — | CN | claimed |
| CN-106749665-B | Conjugates of CC-1065 analogs and bifunctional linkers | 辛塔佳有限公司 | 2021-03-26 | — | — | CN | claimed |
| CN-106466485-A | A kind of targeting ligand-drug coupling body with cell endocytic mediation function | 同宜医药开曼有限公司 | 2017-03-01 | — | — | CN | claimed |
| CN-103118679-B | Conjugates of CC-1065 Analogs and Bifunctional Linkers | SYNTARGA B.V. (NL) | 2016-12-14 | — | — | CN | claimed |
| CN-103118679-A | Novel conjugates of CC-1065 analogs and bifunctional linkers | SYNTARGA BV | 2013-05-22 | — | — | CN | claimed |
| CN-100522249-C | Elongated multiple spacers in activatable prodrugs | SINTAGAR B V (NL) | 2009-08-05 | — | — | CN | claimed |
| CN-101415679-A | Water-soluble CC-1065 analogs and conjugates thereof | SINTAGAR B V (NL) | 2009-04-22 | — | — | CN | claimed |
| CN-1511044-A | Elogated and multiple spacers in activatible prodrugs | — | 2004-07-07 | — | — | CN | claimed |
| CN-118613484-A | Antifolate linker-drug and antibody-drug conjugates | 拜奥迪斯私人有限公司 | 2024-09-06 | — | — | CN | disclosed |
| CN-117794581-A | Conjugates comprising phosphoantigen and their use in therapy | 拜奥迪斯私人有限公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-116617410-A | AXL-specific antibody drug conjugates for cancer treatment | 根马布股份公司 | 2023-08-22 | — | — | CN | disclosed |
| CN-116209476-A | Antifolate linker-drug and antibody-drug conjugates | 拜奥迪斯私人有限公司 | 2023-06-02 | — | — | CN | disclosed |
| CN-114621347-A | Antibodies that bind AXL | 根马布股份公司 | 2022-06-14 | — | — | CN | disclosed |
| CN-109963833-B | Process for the preparation of mono-protected alpha, omega-diaminoalkanes | 拜奥迪斯私人有限公司 | 2022-02-22 | — | — | CN | disclosed |
| CN-106749665-B | Conjugates of CC-1065 analogs and bifunctional linkers | 辛塔佳有限公司 | 2021-03-26 | — | — | CN | disclosed |
| CN-103118679-B | Conjugates of CC-1065 Analogs and Bifunctional Linkers | SYNTARGA B.V. (NL) | 2016-12-14 | — | — | CN | disclosed |
| CN-105899235-A | Method for purifying CYS-linked antibody-drug conjugates | 斯索恩生物制药有限公司 | 2016-08-24 | — | — | CN | disclosed |
| CN-103118679-A | Novel conjugates of CC-1065 analogs and bifunctional linkers | SYNTARGA BV | 2013-05-22 | — | — | CN | disclosed |
| CN-100522249-C | Elongated multiple spacers in activatable prodrugs | SINTAGAR B V (NL) | 2009-08-05 | — | — | CN | disclosed |
| CN-101415679-A | Water-soluble CC-1065 analogs and conjugates thereof | SINTAGAR B V (NL) | 2009-04-22 | — | — | CN | disclosed |